$0.72
-7.8%Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Weak cash conversion. Significant portion of earnings not converting to cashโreview working capital trends and capital intensity.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
WGRX โข NASDAQ
| Wellgistics Health, Inc. Cash Flow Statement | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|
OPERATING ACTIVITIES | |||
-6.9M | -2.9M | -5.3K | |
1.1M | 0.0 | 0.0 | |
1.1M | 0.0 | 0.0 | |
93.4K | 0.0 | 0.0 | |
3.3M | 2.5M | 5.3K | |
-1.2M | -349.1K | 0.0 | |
INVESTING ACTIVITIES | |||
-377.3K | (0.0) | (0.0) | |
(931.4K) | (0.0) | (0.0) | |
-85K | 0.0 | 0.0 | |
(469.1K) | (0.0) | (0.0) | |
FINANCING ACTIVITIES | |||
10K | 500.0 | 0.0 | |
620.7K | 350K | 0.0 | |
1.2M | 0.0 | 0.0 | |
1.8M | 350.5K | 0.0 | |
CASH FLOW SUMMARY | |||
1M | 1.4K | 0.0 | |
1.4K | 0.0 | 0.0 | |
1M | 1.4K | 0.0 | |
-1.6M | -349.1K | 0.0 |
WGRX - Filing history and reports
No SEC filings available for WGRX
Continue your WGRX research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.